Endpoint
WOMAC stiffness subscale
CAT:outcome/womac-stiffness-subscalereported in points1 finding from 1 compound
What moved it
How to read these marks1 finding · 1 compound · by evidence strength
| Compound | Direction | Findings | Strongest evidence |
|---|---|---|---|
| chondroitin sulfate | down | 1 | Evidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence. |
Reported to move it
1 finding
chondroitin sulfate — decreases
Very limitedEvidence strength: very limited. Human evidence with major recorded weaknesses, or non-human, uncontrolled or unverified evidence.Finding“Chondroitin sulfate used alone was also found to be effective in reducing WOMAC total score and stiffness score (P=0.038 and P=0.023, respectively).”
Quoted verbatim from Chondroitin sulfate and/or glucosamine hydrochloride for Kashin-Beck disease: a cluster-randomized, placebo-controlled study.. - Study
- RCT
- Duration
- 6 months
- Population
- adults with Kashin-Beck disease (KBD), chondroitin sulfate monotherapy arm, cluster-randomised trial
Chondroitin sulfate and/or glucosamine hydrochloride for Kashin-Beck disease: a cluster-randomized, placebo-controlled study.2012PMID:22469850Permalink
How it is measured
Western Ontario and McMaster Universities Osteoarthritis Index stiffness subscale, 2 items, administered in Likert (0-8) or visual-analogue format.
Measured, not recorded
- Subject
- womac stiffness subscale
- Measurements
- 1 measurement
- Recorded as a finding
- No
Show what was measured
WOMAC stiffness subscale
decreases, p = 0.001, n = 2002
stiffness (6 articles; 2002 patients; MD= -0.48; 95% CI, -0.77 to -0.19; P = 0.001)
PMID:37198620 · one of two readings recorded this
Sources cited
1 paper
- Subject
- womac stiffness subscale
- Findings
- 1
- Papers
- 1